PMID: 6986319Apr 1, 1980Paper

The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients

Gastroenterology
R J EpsteinE D Thomas

Abstract

We carried out a coded, prospective analysis of sequential rectal biopsies from 13 patients undergoing allogeneic bone marrow transplantation in order to study the accuracy of these biopsies in the diagnosis of acute graft-versus-host disease (GVHD). We also tested the hypothesis that individual crypt cell degeneration is the initial lesion of intestinal GVHD. Pretransplant biopsies were normal. All biopsies taken 7--10 days after transplantation were diffusely abnormal with nuclear atypia and crypt cell degeneration. These changes were due to the conditioning regimen of total body irradiation and chemotherapy and had resolved by day 20 after transplantation. When acute GVHD was present, rectal biopsies were focally abnormal with crypt cell degeneration, crypt dilation, and crypt abscess. Rectal biopsies were normal after day 20 in those patients who did not have clinical evidence of GVHD. The location of cell degeneration at the base of crypts suggests that an immunologic mechanism is responsible for damage to rectal mucosa in GVHD. The rectal biopsy is an accurate way of detecting intestinal involvement with acute GVHD if done after resolution of radiation/chemotherapy effects.

Associated Clinical Trials

Apr 24, 2012·Werner Dolak, MD

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.